Clinical Trial Update: A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This is a Phase I, open-label study of pazopanib in combination with epirubicin or doxorubicin for advanced solid tumors, focusing on breast cancer. The trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxorubicin (doxorubicin)
• Epirubicin (epirubicin)
• Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 1 | Status: COMPLETED